Leichte kognitive Störung

Berit Prinz; Michael Hüll

doi:10.1055/s-0032-1327286

PSYCH up2date, Inhaltsverzeichnis

PSYCH up2date 2013; 7(01): 9-20
DOI: 10.1055/s-0032-1327286

Organische psychische Störungen

Leichte kognitive Störung

Autor*innen

Berit Prinz
Michael Hüll

Abstract

Alle Artikel dieser Rubrik

Volltext

Referenzen

Literatur
1 Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991; 41: 1006-1009
2 Flicker C, Ferris SH, Reisberg B. A longitudinal study of cognitive function in elderly persons with subjective memory complaints. J Am Geriatr Soc 1993; 41: 1029-1032
3 Smith GE, Petersen RC, Ivnik R et al. Subjective memory complaints, psychological distress, and longitudinal change in objective memory performance. Psychol Aging 1996; 11: 272-279
4 Petersen RC, Smith GE, Warning SC et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308
5 Jack CR, Albert MS, Knopman DS et al. Introduction to the recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement 2011; 7: 257-262
6 Albert MS, DeKosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s disease. Alzheimer’s Dement 2011; 7: 270-279
7 McKhann GM, Knopmann DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimer’s Dement 2011; 7: 263-269
8 Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194
9 Perneczky R, Sorg C, Hartmann J et al. Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry 2006; 21: 158-162
10 Giovannetti T, Bettcher BM, Brennan L et al. Characterization of everyday functioning in mild cognitive impairment: a direct assessment approach. Dement Geriatr Cogn Disord 2008; 25: 359-365
11 Petersen RC. Mild cognitive impairment: current research and clinical implications. Semin Neurol 2007; 27: 22-31
12 Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr 2008; 13: 45-53
13 Abdulrab K, Heun R. Subjective memory impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. Eur Psychiatry 2008; 23: 321-330
14 Lopez OL, Jagust WJ, DeKosky ST et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol 2003; 60: 1385-1389
15 Luck T, Riedel-Heller SG, Kaduszkiewicz H et al. Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on aging, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord 2007; 24: 307-316
16 Busse A, Hensel A, Gühne U et al. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006; 67: 2176-2185
17 Bickel H, Mösch E, Seigerschmidt E. Prevalence and persistence of mild cognitive impairment among elderly patients in general hospitals. Dement Geriatr Cogn Disord 2006; 21: 242-250
18 Lyketsos CG, Lopez O, Jones B et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. J Am Med Assoc 2002; 288: 1475-1483
19 Geda YE, Roberts RO, Knopman DS et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry 2008; 65: 1193-1198
20 Morawetz C, Ackermann C, Wormstall H. Psychosoziale Aspekte leichter kognitiver Beeinträchtigungen im Alter. Z Gerontopsychol und -psychiatrie 2001; 14: 137-142
21 Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr 2008; 13: 45-53
22 Schmidtke K, Hermeneit S. High rate of conversion to Alzheimer’s disease in a cohort of amnestic MCI patients. Int Psychogeriatr 2008; 20: 96-108
23 Petersen RC, Thomas RG, Grundman M et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 2379-2388
24 Dickerson BC, Sperling RA, Hyman BT et al. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 2007; 64: 1443-1450
25 Bertram L, Lill C, Tanzi R. The genetics of Alzheimer disease: back to the future. Neuron 2010; 21: 270-281
26 http://www.demenz-leitlinie.de/
27 Klöppel S, Stonnington CM, Chu C et al. Automatic classification of MR scans in Alzheimer’s disease. Brain 2008; 131: 681-689
28 Teipel SJ, Born C, Ewers M et al. Multivariate deformatio-based analysis of brain atrophy to predict Alzheimer’s disease in mild cognitive impairment. Neuroimage 2007; 38: 13-24
29 Fleisher MD, Sun S, Taylor C et al. Volumetric MRI vs. clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 2008; 70: 191-199
30 Mc Evoy LK, Fennema-Noestine C, Rodey JC et al. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 2009; 25: 195-205
31 Hansson O, Zetterberg H, Buchhave P et al. Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228-234
32 Landau SM, Harvey D, Madison CM et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010; 75: 230-238
33 Quigley H, Colloby SJ, O’Brien JT. PET-Imaging of brain amyloid in dementia: a review. Int J Geriatr Psychiatry 2011; 26: 991-999
34 Minoshima S, Frey KA, Koeppe RA et al. A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nuclear Med 1995; 36: 1238-1248
35 Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746
36 Petersen RC, Thomas RG, Grundmann M et al. Vitamin E and donezepil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 2379-2388
37 Winblad B, Gauthier S, Scinto L et al. Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology 2008; 70: 2024-2035 (Erratum Neurology 2010; 75: 1485)
38 Feldman HH, Ferris S, Winblad B et al. Effect of rivastgmine on delay to diagnosis of Alzheimer’s disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2001; 6: 501-512 (Erratum Lancet Neurol 2007; 6: 849)
39 Knopman DS. Current treatment of mild cognitive impairment and Alzheimer’s disease. Curr Neurol Neurosci Rep 2006; 6: 365-371
40 Schneider LS, Insel PS, Weiner MW. Alzheimer’s Disease neuroimaging Initiative. Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer’s Disease Neuroimaging Initiative. Arch Neurol 2011; 68: 58-66
41 Devanand DP, Pelton GH, Marston K et al. Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry 2003; 18: 123-130
42 http://www.depression.versorgungsleitlinien.de/
43 Banerjee S, Heller J, Dewey M et al. Sertralin or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011; 378: 403-411
44 Jean L et al. Cognitive intervention programs for individuals with mild cognitive impairment: systematic review of the literature. Am J Geriatr Psychiatry 2010; 18: 281-296
45 Scarmeas N, Stern Y, Mayeux R et al. Mediterranean diet and mild cognitive impairment. Arch Neurol 2009; 66: 216-225
46 Sofi F, Valecchi D, Bacci D et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. Intern Med 2011; 269: 107-117